Determination of Ribavirin in Serum Using Highly Selective Solid-Phase Extraction and High-Performance Liquid Chromatography
Data up to Jan 2025
Total Citations Per Year
Abstract
References (11)
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 • 3,550 citations
Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C
1998 • 1,318 citations
Ribavirin and interferon alfa‐2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions
1998 • 146 citations
Ribavirin disposition in high-risk patients for acquired immunodeficiency syndrome
1987 • 109 citations
Pharmacokinetics and long-term tolerance to ribavirin in asymptomatic patients infected with human immunodeficiency virus
1991 • 81 citations
High-performance liquid chromatography (HPLC) assay for ribavirin and comparison of the HPLC assay with radioimmunoassay
1989 • 32 citations
Selective purification of reduced oligosaccharides using a phenylboronic acid bond elut column: Potential application in HPLC, mass spectrometry, reductive amination procedures and antigenic/serum analysis
1987 • 24 citations
Quantification of ribavirin in biological fluids and tissues by high-performance liquid chromatography
1987 • 24 citations
High-performance liquid chromatographic determination of ribavirin in serum and urine and of its urinary metabolite 1,2,4-triazole-3-carboxamide
1987 • 21 citations
Comparison of ribavirin and placebo in CDC group III human immunodeficiency virus infection
1991 • 12 citations
Treatment of chronic hepatitis C: another therapeutic option
1996 • 5 citations
Cited By (0)
No citing papers found in database